Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCIG 12-Month Safety and Efficacy in Advanced Parkinson's
NCT00360568Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of levodopa + carbidopa, carbidopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Jun 2009; status: completed.
02
Drugs
levodopa + carbidopacarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00360568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360568.